North America Anesthesia Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The North America Anesthesia Drugs Market is segmented by Drug Type, Route of Administration (Inhalation, Injection, and Other Routes of Administration), Application, and Geography.

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2020
CAGR: 3.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The North American anesthesia drugs market is expected to register a CAGR of nearly 3.5% during the forecast period.

According to the United States Census Bureau’s Statistics, as of 2017, the total number of people aged 65 years and older had exceeded 50 million, and between 2020 and 2030, the number of elderly people is projected to increase by almost 18 million. Although much smaller in total size, the number of people aged 85 years and older is expected to be more than triple from an estimated 6 million in the present scenario, to nearly 20 million by 2060. Elderly patients are likely to be having higher perioperative morbidity and mortality. The older population tends to have more critical diseases, which puts them at an increased risk for perioperative morbidity. The geriatric population is also at a higher risk of organ function failures, as there are changes in the pharmacokinetics and pharmacodynamics related to age and organ function. As the proportion of older patients increases, there will be an increased patient risk with cardiac and pulmonary diseases, alterations in kidney and liver function, and respiratory and urinary tract complications. The overall increase in the number of surgeries performed will have a strong impact on the anesthetics market, thus boosting the growth of the market in this region.

Scope of the Report

Anesthesia is a drug that causes a reversible loss of sensation. There are several types of anesthetic drugs available in the market, such as general anesthesia, spinal anesthesia, IV regional anesthesia, local anesthesia, peripheral nerve block, and saddle block or caudal anesthesia.

By Drug Type
General Anesthesia Drugs
Other General Anesthesia Drugs
Local Anesthesia Drugs
Other Local Anesthesia Drugs
By Route of Administration
Other Routes of Administration
By Application
General Surgeries
Plastic Surgery
Cosmetic Surgeries
Dental Surgeries
Other Applications
North America
United States

Report scope can be customized per your requirements. Click here.

Key Market Trends

Propofol sub-segment by General Anesthesia Drugs, is Expected to Show the Healthy Growth

Propofol is a drug that has been used for a long time for various surgical procedures requiring anesthesia. With the increase in the number of surgeries and the increasing geriatric population in the region, the segment growth also increases. Some of the companies which manufacture propofol injections are Neon Laboratories Limited, Bharat Serums and Vaccines Limited, and Fresenius Kabi, having a good global presence and well-established distribution channel for the drugs in this segment. The drug is always in demand in the market for utilization in different types of surgeries, and is expected to witness rapid growth in the coming years.


To understand key trends, Download Sample Report

Competitive Landscape

The North American anesthesia drugs market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with rising drug approvals, mid-size to smaller companies are increasing their market presence by introducing new ingredients with fewer prices. Companies, like Baxter International, Fresenius SE & Co. KGaA, Eisai Co. Ltd, Roche Holding AG, and B. Braun Melsungen AG, hold substantial market shares in the anesthesia drugs market.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Number of Surgeries

      2. 4.2.2 Growing Investment in R&D by the Pharmaceutical Companies

    3. 4.3 Market Restraints

      1. 4.3.1 Side Effects of General Anesthetics

      2. 4.3.2 Regulatory Issues

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Drug Type

      1. 5.1.1 General Anesthesia Drugs

        1. Propofol

        2. Sevoflurane

        3. Desflurane

        4. Dexmedetomidine

        5. Remifentanil

        6. Midazolam

        7. Isoflurane

        8. Other General Anesthesia Drugs

      2. 5.1.2 Local Anesthesia Drugs

        1. Bupivacaine

        2. Ropivacaine

        3. Lidocaine

        4. Chloroprocaine

        5. Articaine

        6. Benzocaine

        7. Other Local Anesthesia Drugs

    2. 5.2 By Route of Administration

      1. 5.2.1 Inhalation

      2. 5.2.2 Injection

      3. 5.2.3 Other Routes of Administration

    3. 5.3 By Application

      1. 5.3.1 General Surgeries

      2. 5.3.2 Plastic Surgery

      3. 5.3.3 Cosmetic Surgeries

      4. 5.3.4 Dental Surgeries

      5. 5.3.5 Other Applications

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico


    1. 6.1 Company Profiles

      1. 6.1.1 Aspen Holdings

      2. 6.1.2 AbbVie Inc.

      3. 6.1.3 AstraZeneca

      4. 6.1.4 Baxter International

      5. 6.1.5 B. Braun Melsungen AG

      6. 6.1.6 Eisai Co. Ltd

      7. 6.1.7 Pfizer Inc.

      8. 6.1.8 F. Hoffmann-La Roche AG

      9. 6.1.9 Fresenius SE & Co. KGaA

      10. 6.1.10 Novartis AG (Sandoz)

      11. 6.1.11 Piramal Enterprises Limited

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Anesthesia Drugs Market market is studied from 2018 - 2026.

The North America Anesthesia Drugs Market is growing at a CAGR of 3.5% over the next 5 years.

B. Braun Melsungen AG, Baxter International, Eisai Co., Ltd., Fresenius SE & Co. KGaA, AbbVie Inc. are the major companies operating in North America Anesthesia Drugs Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!